Cytokines are involved in the development of several inflammatory diseases and atherosclerosis. Their variations in healthy individuals are not well defined. The aims of this study were: firstly, to identify factors affecting biological variation of interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-a); secondly, to study their family resemblance; and thirdly, to evaluate the effect of two TNF-a (À308G/A and À238G/A) and two IL-6 polymorphisms (174G/C and À572G/C) on their corresponding circulating levels. A total of 171 healthy families selected from the STANISLAS cohort were studied. Age was negatively related to TNFa concentrations in offspring only (both sons and daughters). Additionally, IL-6 and TNF-a levels were differently influenced by gender, white blood cells, tobacco consumption, and HDL-cholesterol level. A weak significant familial resemblance for TNF-a concentration was observed in siblings only. There was no significant familial resemblance for IL-6 levels. The TNF-a À308A allele was associated with decreased TNFa concentrations in both offspring aged less than 18 and males without overweight (BMIo25 kg/m 2 ). Fathers carrying the IL-6 À174CC genotype had higher IL-6 levels than those with the IL-6 À174G allele. Parents with the IL-6 À572GG genotype had higher IL-6 concentrations than the C allele carriers. In this sample of healthy families, plasma levels of IL-6 and TNF-a were differently affected by biological parameters including age, gender and smoking, and the impact of their respective polymorphisms was influenced by gender, age and BMI.
Introduction
Chronic inflammatory process atherosclerosis plays an important role in both initiation and progression of coronary and peripheral artery atherosclerosis. 1 The genesis of the atherosclerotic plaque depends on interaction of cellular components of the immune system such as cytokines and cell adhesion molecules, with lipids, platelets, and endothelial cells. Tumour necrosis factor alpha (TNF-a) is a proinflammatory cytokine, 2, 3 mainly produced by monocytes, macrophages, 4 and by T and B lymphocytes. 5, 6 TNF-a plasma concentrations increase in patients affected with premature coronary artery disease 7 and is involved in obesity and insulin resistance. 8, 9 Its expression is regulated at the transcriptional level. 10 Recently, a polymorphism affecting TNF-a transcription has been identified in the promoter region of the gene, at nucleotide position À308.
11
Padovani et al 12 have shown that this polymorphism may increase the risk of myocardial infarction (MI) in obese subjects. Moreover, Collins et al 13 have found a significant association between Alzheimer's disease (AD) and a haplotype that included the À308 polymorphism and the TNF-a À238G/A polymorphism, in addition to a significant association involving solely the À238 polymorphism. Interleukin-6 (IL-6) is a circulating cytokine secreted by activated macrophages and lymphocytes.
14 Adipose tissue produces up to 30% of its total circulating concentration in healthy subjects. 14, 15 Circulating levels of IL-6 are elevated in coronary heart disease. 16 , 17 Fishman et al, 18 have identified a G/C polymorphism at nucleotide -174 within the promoter of IL-6 gene that could modify its expression. This polymorphism may also contribute to the susceptibility to type I diabetes 19, 20 and lipid abnormality. 21 Another potentially functional IL-6 polymorphism (À572G/C) has been recently identified. 22 Biological and genetic variations of TNF-a and IL-6 have never been defined in a healthy family population including children. Therefore, the objective of this study realised in such a population was to identify the factors affecting biological variation of these two molecules, to study their familial resemblance, and also to search for associations between their gene polymorphisms and the expression of the corresponding proteins.
Methods and materials
Subjects and data collection The studied population was a sample of the STANISLAS cohort, a longitudinal family study previously described, 23 designed to investigate factors related to cardiovascular disease. Participants were Caucasian and came from the Vosges and the South of Meurthe-et-Moselle (Eastern part of France). The members of the 171 families selected were apparently in good health, not under lipid-lowering and/or cardiovascular drug treatment and free from known serious and/or chronic illnesses; no one demonstrated clinical, biochemical or haematological proof of cardiovascular, hepatic or renal failure. Each subject gave a written informed consent for participating in this study, which was approved by the Local Ethics Committee.
The data collection included measurements of basic blood constituents, physical examination and medical history. Information on drug intake (notably anti-inflammatory drugs, oral contraceptives), assessing smoking status and alcohol consumption, were obtained.
Blood sample and analysis
Blood samples were collected after an overnight fast, in the morning between 9 and 10 h. Serum and plasma samples were separated by centrifugation at 2000 g for 15 min. Serum cholesterol and triglyceride (TG) levels were measured using standard enzymatic methods (Merck, Darmstadt, Germany) on an automated analyser AU5021 (Olympus, Japan), and serum HDL-C was assessed after precipitation of apolipoprotein B-containing particles by phosphotungstic acid-MgCl 2 on a Cobas-Mira (Roche Diagnostic systems, France).
Blood samples for TNF-a and IL-6 were treated within 2 h (centrifugation within 1 h, and freezing (liquid nitrogen) within 2 h after blood was collected), and circulating plasma levels of IL-6 and TNF-a were measured by a commercially available enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Abington, UK). The intraassay coefficient of IL-6 and TNF-a variations was 7.0% and the inter-assay coefficients were 14.0 and 13.0% respectively. Body mass index (BMI) was calculated according to Quetelet's formula: weight (kg)/height (m 2 ). The genotyping of individuals for the TNF-a À308G/A, TNF-a À238G/A, IL-6 À174 G/C and IL-6 À572 G/C polymorphisms was performed using a multiplex assay, as described previously. 24 
Statistical analysis
Data for IL-6, TNF-a and HDL-cholesterol were logtransformed before statistical analysis to reduce the skewness of the distributions. Statistical analysis was performed with SAS software (SAS Institute Inc., USA). As individuals within a family are not independent, statistical analyses were based on the generalised estimating equation (GEE) technique, 25 using the SAS GENMOD procedure with a repeated statement. Multiple regression analysis was used to determine factors of biological variation of TNF-a and IL-6 concentrations in each group of relatives (fathers, mothers, sons and daughters). The following parameters have been tested as confounding variables: age, BMI, white blood cells, tobacco and alcohol consumption, antiinflammatory and contraceptive drug intake, and HDLcholesterol. Family correlations for TNF-a and IL-6 concentrations were estimated by the GEE technique. 26 Hardy-Weinberg equilibrium was tested for the studied polymorphisms by a chi-square test (w 2 ). Linkage disequilibrium between pairs of loci was tested by the Arlequin software. Associations between TNF-a polymorphisms (À308G/A and À238G/A) and TNF-a circulating levels, and between IL-6 polymorphisms (À572G/C and À174G/ C) and IL-6 circulating levels were tested using the SAS GENMOD procedure. Due to the small number of individuals homozygous for the less frequent allele, homozygotes have been pooled with the corresponding heterozygotes for the statistical analysis. Statistical significance was set at Po0.05. For multiple correlations Bonferroni correction was applied and significance was set at Pp0.01.
Results
General characteristics of the studied population are given in Table 1 . IL-6 showed a strong and positive correlation with TNF-a (data not shown).
Biological determinants of IL-6
Factors of biological variation of IL-6 concentration were gender, age, BMI, tobacco, white blood cells and HDLcholesterol concentration. In the overall population, sons had lower IL-6 concentrations than fathers (P ¼ 0.01), whereas IL-6 concentrations were higher in daughters than in mothers (P ¼ 0.046). Fathers had higher IL-6 concentrations than mothers, but no statistical difference was observed between sons and daughters ( Table 1 ). Figure 1a shows the variation of IL-6 concentrations according to age. In offspring, IL-6 concentrations decreased significantly with age in both genders (P ¼ 0.02). Over age 20 years old, IL-6 levels in offspring reached those of the youngest parents (p45 years). Then IL-6 concentrations increased with age in parents (P ¼ 0.025). These two statistical differences were obtained with monoparametric analysis. In a second step, independent determinants of IL-6 plasma concentrations in parents and offspring were searched using a multiparametric analysis (Table 2 ). In this case, age was not found not to be a determinant. White blood cell (WBC) number was significantly associated with increased IL-6 concentrations in sons (Pp0.001). Tobacco consumption was significantly related to IL-6 concentrations in fathers only (Pp0.01). HDL-cholesterol concentration showed a significant negative relationship with IL-6 concentrations in daughters (Pp0.01).
The main factor for IL-6 variation was: tobacco in fathers (R 2 ¼ 9.1%), HDL-cholesterol in daughters (R 2 ¼ 4%) and
Biological determinants of TNF-a Biological determinants of TNF-a concentration were tobacco in fathers, age in mothers and in children. TNF-a levels were significantly higher in offspring than in parents, (Pp0.001 in males and in females). No difference according to gender was observed (Table 1 ). Figure 1b shows the variation of TNF-a concentrations according to age. In offspring, TNF-a concentration decreased considerably (from 3.75 to 1.40) with age (Po0.001). In parents, no significant variation of TNF-a levels with age was observed. Independent determinants of TNF-a plasma concentrations in parents and offspring are presented in Table 3 . Tobacco consumption was significantly and negatively associated with TNF-a levels in fathers only (Pp0.01). The total percentage of TNF-a variation explained by age in offspring was 3.8 and 6% in sons and daughters, respectively. In fathers, tobacco consumption explained 5.7% of the variability of TNF-a level. (Table 4 , model 2). No significant familial correlation was observed for IL-6 concentration before and after adjustment for IL-6 covariates (Table 5) .
Relations between TNF-a polymorphisms and TNF-a concentration The À308G/A and À238G/A TNF-a genotype distributions did not differ from that expected by the Hardy -Weinberg equilibrium ( Table 6 ). The frequency of the TNF-a À308A allele was 0.104 and that of the TNF-a À238A allele was 0.063. The two loci were in linkage disequilibrium (w 2 ¼ 5.59, P ¼ 0.018). In the overall population, individuals bearing the TNF-a À308GG genotypes tended to have higher TNF-a levels than carriers of the A allele (P ¼ 0.06) ( Table 7 ). In fact, the TNF-a À308 G/A polymorphism was associated with decreased TNF-a concentrations in the offspring aged less than 18 years (P ¼ 0.04). A significant interaction between the À308G/A TNF-a polymorphism and BMI was observed in males on TNF-a levels (P ¼ 0.031 after adjustment for covariates in each family relative). TNF-a decreased in males with BMI in individuals with the GG genotype (b ¼ À0.01970.009, Po0.05), whereas no significant relationship was observed in the A allele carriers (b ¼ 0.02270.015, Po0.20). Consequently, the GG genotype was related to higher TNF-a levels in normal weight male subjects (BMIo25 kg/m 2 ) (P ¼ 0.0045), whereas no significant effect was observed in overweight male subjects (BMIX25 kg/m 2 ) (P ¼ 0.27) ( Table 8 ). The À308G/A TNF-a polymorphism explained 3.5% of the TNF-a level in men whose BMI was below 25 kg/m 2 .
Relations between IL-6 polymorphisms and IL-6 concentration The IL-6 À572G/C and IL-6 À174G/C genotypes distributions are presented in Table 6 . They did not differ from that expected by the Hardy -Weinberg equilibrium. The frequency of the À572C allele was 0.053 and that of the À174C allele was 0.395. The two loci were in linkage disequilibrium (w 2 ¼ 24.97, Po0.001), the À572CC geno- 
Values are n (%).
TNF-a and IL-6 concentrations N Haddy et al type being more frequently associated with the À174GG genotype.
A relationship between IL-6 levels and À174G/C polymorphism was only observed in fathers (P ¼ 0.018, 1% of explained variation) and a relationship between IL-6 levels and À572G/C polymorphism was found in both parents (P ¼ 0.026, 1.22% of explained variation) ( Table 9 ). Fathers with the À174CC genotype had higher IL-6 levels than those with the À174G allele and parents with the À572GG genotype had higher IL-6 concentrations than carriers of the C allele.
Discussion
Biological and genetic determinants of plasma TNF-a and IL-6 concentrations have been investigated in a healthy family-based population. Gender, age, tobacco consumption, BMI, WBC and HDL-C influenced differently IL-6 and TNF-a concentrations. Contrary to TNF-a, plasma IL-6 levels were significantly different according to gender. However, previous studies did not find sex effect on IL-6.
27
TNF-a concentrations decreased with age in both genders for offspring. After a multi-parameter analysis, age was shown to be a determinant of TNF-a circulation level in offspring only (both sons and daughters). However, age was not a determinant of IL-6 level in any group (father, mother, sons or daughters). This is the first study on the variations of IL-6 and TNF-a levels with age, including children and middle-aged subjects (from 5 to 56 years). An other study was realised with children only, aged from 3 to 17 years old, but no statistical analysis was performed. 28 In the present study, a continuous decrease was observed in TNF-a between 5 and 17 years, whereas Sack et al 28 found
an increase in TNF-a level between 5 and 10 years and, and a decrease between 10 and 15 years. However, TNF-a concentrations were very high in some subjects (around 100 pg/ml). In the literature, other studies concern populations aged from more than 15 years old. They also include adults in their statistics, and the effects of age are given by correlation coefficients in the entire population, without taking into account the effect of other parameters. In the present familial study, parents were studied independently of children. Moreover, not only coefficient of regression calculations but also multiparametric searches were done for determination of variations. Generally, other studies give an increase of IL-6 after adolescence. 27,29 -31 Few informations exist on the variation of TNF-a. Values could increase in women. 31 We only found variations in offspring. Metabolic pathways underlying the age-related variation in IL-6 are still under investigation. 27 Effect of puberty and menopause have been checked in our study. No effect has been proved to be significant. Smoking was associated with IL-6 and TNF-a concentrations in fathers only. No relation was observed in mothers and offspring probably because of the modest tobacco Table 7 Association between À308 G/A TNF-a polymorphism and TNF-a circulating levels Log TNF-a values are mean7standard error adjusted on age for fathers and sons, tobacco for fathers. Table 9 Association between -572G/C, -174G/C IL-6 polymorphisms and IL-6 concentration TNF-a and IL-6 concentrations N Haddy et al consumption. The fact that IL-6 was positively correlated to tobacco consumption is in agreement with previous studies. 32, 33 TNF-a and tobacco consumption were negatively related. Recent studies in healthy men showed that smoking status had no effect on TNF-a concentrations. 32, 34 Macrophage cells secrete more TNF-a in the presence of lower concentrations of smokeless tobacco than in the presence of higher concentrations. 35 Vayssier et al 36 also
observed, as we did, that tobacco was related with decreased TNF-a concentrations, and concluded that it could abolish TNF-a cellular release. BMI was not associated with IL-6 or TNF-a. Numerous contradictory reports exist in the literature. 27,37 -39 Familial factors appear to have a modest impact on TNFa and IL-6 levels, as no significant familial correlation for IL-6 and a small one were observed for TNF-a in offspring. However, genetic variants in TNF-a and IL-6 genes could affect their respective gene product concentration with modulation by the context (ie gender, age and BMI).
IL-6 and TNF-a familial resemblances are in contradiction with those of Pantsulaia et al 27 who showed a strong familial resemblance especially for IL-6 (heritability about 80%) and about 24% for TNF-a. The only difference in methodology is that, in our study, plasma was stored in liquid nitrogen before analysis. In the Pantsulaia study, samples were kept frozen at À801C instead of liquid nitrogen. The discrepancy may be due to the different origins and ages of the two populations. This last population, aged from 18 to 75 years, was collected from small villages (Russian federation). The impact of genetic and/or environmental factors may be more important in such isolated populations. The relationship between TNF-a -308G/A polymorphism and TNF-a levels was dependent on age and BMI. The TNFa -308A allele was related to decreased TNF-a levels in offspring (ager18 years) and in normal-weight male subjects (BMIo25 kg/m 2 ). Overweight may be not sufficient to produce a significant effect on the relation between the genotype and TNF-a levels, and to observe increased TNF-a levels with the A allele in overweight subjects. This is in agreement with the fact that obesity can induce an inappropriate secretion of IL-6 and TNF-a. 40, 41 No relation was observed between the TNF-a À238G/A polymorphism and TNF-a level. Contradictory results may be found in the literature: both an increase 41 -43 and a decrease 44 in TNF-a protein expression can be associated with the À238A allele. Men with the À174CC genotype and adults with the À572GG genotype had higher IL-6 levels, the two genotypes being in linkage disequilibrium. This association between À174C allele and higher levels of plasma IL-6 is supported by another study of patients with aneurysmal disease, where subjects with the C allele had higher IL-6 levels and higher mortality. 45 However, Fishman et al 18 found that the C allele was associated with lower IL-6 levels in a small group of healthy men and women aged from 40 to 75 years old. The À174 G/C polymorphism could exhibit different effects in individuals older than those included in the present study (men 38 -56 years old). Our results are in agreement with Brull et al, 46 who found the C allele related to increased IL-6 levels in patients after coronary artery bypass. Consistent with these findings, the C allele was associated positively with C-reactive protein (CRP), 47, 48 and IL-6 was reported as the primary determinant of the hepatic production of CRP. 49 In addition, the C allele was more common in men affected with MI than in controls 50 and IL-6 was found elevated in coronary heart disease patients. 16, 17 The newly identified -572G/C IL-6 polymorphism 22 is still less studied than the À174G/C IL-6 polymorphism. For the first time, in a healthy population, a relationship has been shown between this polymorphism and IL-6 levels, the adults with the À572GG genotype having an increased IL-6 level compared with the carriers of the C allele. Brull et al 46 showed that the IL-6 -572C allele was related to increased Il-6 levels in patients after coronary artery bypass, whereas Humphries et al 51 found that the IL-6 À572G/C polymorphism was not associated with CHD risk in healthy men.
Conclusion
In conclusion, we have determined, for the first time, the main biological factors affecting IL-6 and TNF-a concentrations in a healthy family population including children. We have also shown genetic influences on TNF-a and IL-6 plasma concentrations involving environmental factors. Two of them are of particular interest as they could concern the risk of cardiovascular disease, although this is in debate. If this is confirmed, it could help in the prevention of this pathology.
